Japan Diabetes Market Report and Forecast
Upcoming SlideShare
Loading in...5
×
 

Japan Diabetes Market Report and Forecast

on

  • 530 views

 

Statistics

Views

Total Views
530
Views on SlideShare
529
Embed Views
1

Actions

Likes
0
Downloads
1
Comments
0

1 Embed 1

http://paper.li 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Japan Diabetes Market Report and Forecast Japan Diabetes Market Report and Forecast Document Transcript

  • About IMARCFor more than 5 years, the International Market Analysis Research and Consulting Group hasbeen a leading advisor on management strategy and market research worldwide. We partnerwith clients in all sectors and regions to identify their highest-value opportunities, address theirmost critical challenges, and transform their businesses.IMARCs information products include major market, scientific, economic and technologicaldevelopments for business leaders in pharmaceutical, industrial, and high technologyorganizations. Market forecasts and industry analysis for biotechnology, advanced materials,pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processingmethods are at the top of the companys expertise.IMARC’s tailored approach combines unfathomable insight into the dynamics of companies andmarkets with close cooperation at all levels of the client organization. This ensures that ourclients achieve unmatchable competitive advantage, build more proficient organizations, andsecure lasting results.
  • About The ReportIMARC’s new report “Japan Diabetes Market Report & Forecast 2011-2016” provides ananalytical and statistical insight into the Japanese diabetes market. The report provides bothcurrent and future trends in the prevalence, demographical breakup, diagnosis and treatmentof diabetes in Japan. The report has segmented the Japanese diabetes market into twosegments – Insulin and the Oral Antidiabetics market. For each of the aforementionedcategories, the report provides historical and future market sales of key classes, keycompanies, key drugs and key molecules.The research study serves as an exceptional tool to understand the market trends,therapeutic structure, competitive structure and the outlook of the Japanese diabetes markettill 2016. This report can serve as an excellent guide for investors, researchers, consultants,marketing strategists and all those who are planning to foray into the Japanese diabetesmarket in some form or the other.Key Questions Answered in this Report: What is the size and demographical breakup of the diabetes population in Japan? What are the current and future diagnosis and drug treatment rates of diabetes in Japan? How has the diabetes market behaved since 2005 and what are the expected trends till 2016? What has been the historical performance of the Japanese Insulin market during 2005- 2010 and its outlook till 2016? What has been the performance of top classes, top players, top molecules and top drugs in the Insulin market during 2005-2010? What has been the historical performance of the Oral Antidiabetics market during 2005- 2010 and its outlook till 2016? What has been the performance of top classes, top players, top molecules and top drugs in the Oral Antidiabetics market during 2005-2010?
  • Why should you buy this report? Gain a deeper understanding about the prevalence, diagnosis and treatment of diabetes in Japan and identify your potential patient pool. Analyze the historical, current and future trends in the Insulin and Oral Antidiabetics market to identify potential classes, drugs, partners and competitors for market entry and expansion plans. Develop Investment strategies by identifying companies that have been the biggest winners and losers in the Japanese Insulin and Oral Antidiabetics market. Gain an insight into future market events such as patent expiry’s and new product launches.Classes Covered:Fast acting Insulins, Long acting Insulins, Intermediate and Fast acting Insulins, Intermediateacting Insulins, Biguanides, Glitazone and Biguanide combinations, Glinides, Sulphonylureas,Glitazones, DPP-IV Inhibitors, DPP-IV Inhibitor and Glitazone Combinations, Glinide andBiguanide Combinations, Glp-1 Agonists, Alpha-Glucosidase Inhibitors, SGLT Inhibitors andall other Oral Antidiabetic classes.Information Sources:Information has been sourced from both primary and secondary sources:  Primary sources include industry surveys and face to face/telephonic interviews with physicians and industry experts.  Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.Forecasting Methodology:IMARC generates its product and market forecasts utilizing its extensive database ofmacroeconomic and sector specific data. The initial baseline forecast is generated with themost recent market data. After an initial baseline forecast, all future macroeconomic andsector specific events and assumptions are taken into account to generate the final forecast.
  • Table of Contents1 Research Methodology & Market Definitions ............................................................................... 82 Executive Summary ..................................................................................................................... 103 Epidemiology ............................................................................................................................... 13 3.1 Total Diabetes Patients ........................................................................................................ 13 3.2 Patients by Gender............................................................................................................... 14 3.3 Patients by Age Group ......................................................................................................... 15 3.4 Diagnosed and Drug Treated Population ............................................................................ 164 Market Dynamics ......................................................................................................................... 17 4.1 Diabetes Market.................................................................................................................... 17 4.1.1 Current Trends (2005–2010) ........................................................................................... 17 4.1.2 Market Forecast (2011-2016) .......................................................................................... 18 4.2 Insulin Market ....................................................................................................................... 19 4.2.1 Current Trends (2005-2010) ........................................................................................... 19 4.2.1.1 Market by Class .......................................................................................................... 20 4.2.1.2 Market by Molecule..................................................................................................... 21 4.2.1.3 Top Players ................................................................................................................ 23 4.2.1.4 Top Drugs................................................................................................................... 24 4.2.2 Forecast (2011-2016) ..................................................................................................... 26 4.3 Oral Antidiabetics................................................................................................................. 27 4.3.1 Current Trends (2005-2010) ........................................................................................... 27 4.3.1.1 Market by Class .......................................................................................................... 28 4.3.1.2 Top Players ................................................................................................................ 30 4.3.1.3 Top Drugs................................................................................................................... 32 4.3.2 Forecast (2011-2016) ..................................................................................................... 34
  • List of FiguresFigure 3-1: Japan: Number of Diabetes Patients* (in 000’s), 2010, 2015, 2020, 2025 & 2030 .......................... 13Figure 3-2: Japan: Breakup of Diabetes Patients by Gender (in 000’s), 2010, 2015, 2020, 2025 & 2030 ......... 14Figure 3-3: Japan: Breakup of Diabetes Patients by Gender (in %) 2010, 2015, 2020, 2025 & 2030 ................ 14Figure 3-4: Japan: Breakup of Diabetes Patients by Age Group (in 000’s), 2010, 2015, 2020, ......................... 15Figure 3-5: Japan: Breakup of Number of Diabetes Patients by Age Group (in %) ............................................ 15Figure 3-6: Japan: Diagnosed & Drug Treated Share of Population Forecast, (in Million) 2010, 2015 & 2020 .. 16Figure 4-1: Japan: Diabetes Market (in Million US$), 2005-2010 ....................................................................... 17Figure 4-2: Japan: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2005-2010 ................... 17Figure 4-3: Japan: Diabetes Market Forecast (in Million US$), 2010-2016 ........................................................ 18Figure 4-4: Japan: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2016 ................... 18Figure 4-5: Japan: Insulin Market, (in Million US$), 2005-2010 .......................................................................... 19Figure 4-6: Japan: Breakup of Insulin Market by Class (in %), 2005-2010 ......................................................... 20Figure 4-7: Japan: Breakup of Insulin Market by Molecule (in %), 2005-2010 ................................................... 22Figure 4-8: Japan: Insulin Market: Share of Key Players (in %), 2005-2010 ...................................................... 23Figure 4-9: Japan: Insulin Market: Share of Key Drugs (%), 2005-2010............................................................. 25Figure 4-10: Japan: Insulin Market Forecast (in Million US$), 2011-2016 .......................................................... 26Figure 4-11: Japan: Oral Antidiabetics Market: (in Million US$), 2005-2010 ...................................................... 27Figure 4-12: Japan: Oral Antidiabetics Market: Share by Class (%), 2005-2010 ................................................ 29Figure 4-13: Japan: Oral Antidiabetics Market: Share of Key Players (%), 2005-2010 ...................................... 30Figure 4-14: Japan: Oral Antidiabetics Market: Share of Key Drugs (%), 2005-2010 ......................................... 33Figure 4-15: Japan: Oral Antidiabetics Market: Forecast (in Million US$), 2011-2016 ....................................... 35Figure 4-17: Japan: Oral Antidiabetics Market: Share by Class Forecast (%), 2010-2016 ................................. 36
  • List of TablesTable 1-1: Japan: Diabetes Market: Market Definitions ........................................................................................ 8Table 2-1: Japan: Diagnosed & Drug Treated Population in Million, 2010, 2015 & 2020 ................................... 16Table 3-1: Japan: Breakup of Insulin Market by Class (in Million US$), 2005-2010 ........................................... 20Table 3-2: Japan: Breakup of Insulin Market by Molecule (in Million US$), 2005-2010 ...................................... 21Table 3-3: Japan: Insulin Market: Sales of Key Players (in Million US$), 2005-2010 ......................................... 23Table 3-4: Japan: Insulin Market: Sales of Top Drugs (in Million US$), 2005-2010 ........................................... 25Table 3-5: Japan: Oral Antidiabetics Market: Sales by Class (in Million US$), 2005-2010 ................................. 28Table 3-6: Japan: Oral Antidiabetics Market: Sales of Key Players (in Million US$), 2005-2010 ....................... 30Table 3-7: Japan: Oral Antidiabetics Market: Sales of Top Drugs( in Million US$), 2005-2010 .......................... 32Table 3-8: Japan: Oral Antidiabetics Market: New Drug Launches (2011-2016) ................................................ 34Table 3-9: Japan: Oral Antidiabetics Market: Sales by Class Forecast, (in Million US$), 2010, 2013 & 2016.... 35
  • Prices and Order Information Electronic Access Electronic Access CD-ROM Mail Delivery Hard Copy Mail Delivery(Single User License) (Multi User License) (Single User License) (Single User License) US$ 750 US$ 1300 US$ 900 US$ 900 For more information visit: http://www.imarcgroup.com/japan-diabetes-market-report-forecast-2011- 2016/ To buy the complete report or to get a free sample: Call: +91-120-425-6531 (Asia), +44-844-774-9660 (Europe), +1-631-791-1145 (America) Email:sales@imarcgroup.com